Skip to main content
. 2016 Jan 27;7(19):27033–27043. doi: 10.18632/oncotarget.7041

Figure 6. CRC-EV-treated Jurkat cells promote tumor progression.

Figure 6

A. Cell viability of DLD-1 cells co-cultured with Jurkat cells or CRC-EV-treated Jurkat cells for 48 h in a well with a partition of the 4 μm porous filter. B. Tumor volumes of DLD-1 cell-xenografted mice injected with PBS, Jurkat cells, or CRC-EV-treated Jurkat cells around the tumors. C. Viability of DLD-1 cell-derived spheroids co-cultured with Jurkat cells or CRC-EV-treated Jurkat cells for 72 h evaluated by the MTT assay. The P values in “A”, “B” and “C” are indicated as follow: *P < 0.05 and **P < 0.01. Jurkat cells were incubated with CRC-EVs for 48 h before the co-culture with DLD-1 cells A., spheroids C. or the injection B.